Cyclobenazprine



Indications and Reactions:

Role Indications Reactions
Primary
Muscle Spasms 18.2%
Neck Pain 18.2%
Back Pain 9.1%
Fibromyalgia 9.1%
Intervertebral Disc Degeneration 9.1%
Muscle Relaxant Therapy 9.1%
Muscle Strain 9.1%
Pain 9.1%
Road Traffic Accident 9.1%
Circulatory Collapse 8.3%
Facial Palsy 8.3%
Mental Status Changes 8.3%
Product Substitution Issue 8.3%
Psychotic Disorder 8.3%
Respiratory Arrest 8.3%
Restlessness 8.3%
Somnolence 8.3%
Suicidal Ideation 8.3%
Swelling Face 8.3%
Treatment Failure 8.3%
Tremor 8.3%
Secondary
Product Used For Unknown Indication 48.1%
Neck Pain 6.2%
Diabetes Mellitus 4.7%
Fibromyalgia 4.7%
Musculoskeletal Pain 4.7%
Rheumatoid Arthritis 4.7%
Anaemia 3.1%
Coronary Artery Disease 3.1%
Gastritis 3.1%
Systemic Lupus Erythematosus 3.1%
Analgesic Therapy 1.6%
Blood Testosterone Decreased 1.6%
Cough 1.6%
Depression 1.6%
Hypersensitivity 1.6%
Nasal Congestion 1.6%
Pain Management 1.6%
Prophylaxis Against Gastrointestinal Ulcer 1.6%
Sleep Apnoea Syndrome 1.6%
Asthenia 0.8%
Completed Suicide 20.7%
Toxicity To Various Agents 10.3%
Back Pain 6.9%
Bowel Movement Irregularity 6.9%
Cardiac Arrest 6.9%
Tachycardia 6.9%
Abdominal Pain Upper 3.4%
Agitation 3.4%
Angina Pectoris 3.4%
Chest Pain 3.4%
Circulatory Collapse 3.4%
Fall 3.4%
Hypersensitivity 3.4%
Intentional Drug Misuse 3.4%
Respiratory Arrest 3.4%
Septic Shock 3.4%
Urinary Retention 3.4%
Visual Impairment 3.4%
Concomitant
Product Used For Unknown Indication 30.2%
Pain 10.9%
Migraine 5.7%
Hypertension 5.4%
Rheumatoid Arthritis 5.2%
Fibromyalgia 4.3%
Depression 4.1%
Premenstrual Syndrome 4.1%
Asthma 3.9%
Bipolar Disorder 2.9%
Polycystic Ovaries 2.9%
Insomnia 2.7%
Sleep Disorder 2.5%
Arthritis 2.3%
Gastrooesophageal Reflux Disease 2.3%
Nausea 2.3%
Vitamin Supplementation 2.3%
Anxiety 2.0%
Muscle Relaxant Therapy 2.0%
Muscle Spasms 2.0%
Cholecystitis Chronic 7.5%
Economic Problem 7.5%
Weight Decreased 7.5%
Alopecia 5.7%
Anxiety 5.7%
Chest Pain 5.7%
Deep Vein Thrombosis 5.7%
Nausea 5.7%
Off Label Use 5.7%
Vomiting 5.7%
Cholecystitis Acute 3.8%
Depression 3.8%
Drug Ineffective 3.8%
General Physical Health Deterioration 3.8%
Headache 3.8%
Injury 3.8%
Mental Disorder 3.8%
Mental Status Changes 3.8%
Ovarian Cyst 3.8%
Pneumonia 3.8%
Interacting
Atrial Fibrillation 33.3%
Back Disorder 33.3%
Back Pain 33.3%
Electrocardiogram Qt Prolonged 100.0%